Skip to main content
. 2021 Jul 13;11:14375. doi: 10.1038/s41598-021-93763-y

Table 4.

Disproportionality data analysis.

N IC (95% CI) PRR (95% CI)
Levofloxacin
Arthralgia 4231 1.75 (1.71–1.80) 3.41 (3.31–3.51)
Pain in extremity 2865 1.52 (1.47–1.58) 2.90 (2.79–3.00)
Tendonitis 4742 6.09 (6.06–6.13) 96.65 (93.50–99.80)
Tendon pain 1847 6.29 (6.22–6.36) 120.88 (114.32–127.43)
Myalgia 2373 1.23 (1.17–1.28) 2.35 (2.26–2.44)
Tendon disconfort 137 5.74 (5.49–5.99) 91.45 (75.07–107.83)
Tendon disorder 1995 6.27 (6.20–6.34) 117.35 (111.25–123.45)130
Ciprofloxacin
Arthralgia 3504 1.26 (1.22–1.31) 2.42 (2.34–2.50)
Tendonitis 2714 5.07 (5.01–5.12) 40.38 (38.77–41.99)
Pain in extremity 2054 0.82 (0.76–0.89) 1.78 (1.70–1.85)
Myalgia 2021 0.78 (0.71–0.84) 1.72 (1.65–1.79)
Muscular weakness 880 0.97 (0.87–1.06) 1.96 (1.84–2.09)
Tendon discomfort 130 5.48 (5.23–5.73) 73.09 (59.80–86.38)
Tendon disorder 920 4.94 (4.84–5.04) 36.59 (34.12–39.06)
Tendon pain 1475 5.75 (5.68–5.82) 75.11 (70.77–79.45)
Moxifloxacin
Arthralgia 865 0.70 (0.61–0.80) 1.63 (1.53–1.74)
Tendonitis 514 4.11 (3.99–4.24) 18.14 (16.62–19.66)
Tendon disorder 195 4.12 (3.91–4.33) 18.71 (16.23–21.19)
Myalgia 569 0.41 (0.29–0.53) 1.33 (1.22–1.43)
Tendon pain 285 4.8 (4.63–4.97) 30.75 (27.31–34.20)
Tendon discomfort 13 3.29 (2.40–4.18) 15.19 (8.75–21.63)
Ofloxacin
Arthralgia 521 0.60 (0.48–0.73) 1.52 (1.40–1.64)
Tendonitis 674 5.12 (5.01–5.23) 37.23 (34.51–39.96)
Tendon disorder 260 5.13 (4.95–5.31) 39.09 (34.54–43.63)
Myalgia 422 0.61 (0.46–0.75) 1.52 (1.39–1.66)
Tendon pain 113 4.06 (3.78–4.34) 18.28 (15.18–21.38)
Tendon discomfort 12 3.55 (2.62–4.48) 21.67 (12.22–31.12)
Norfloxacin
Tendonitis 369 5.04 (4.89–5.19) 35.18 (31.78–38.59)
Arthralgia 235 0.27 (0.08–0.46) 1.21 (1.06–1.35)
Myalgia 209 0.41 (0.20–0.61) 1.33 (1.16–1.49)
Tendon disorder 54 3.61 (3.20–4.03) 13.79 (10.55–17.02)
Tendon pain 55 3.76 (3.36–4.17) 15.49 (11.88–19.09)
Tendon discomfort 11 3.81 (2.83–4.79) 34.89 (19.20–50.58)

Bolded text represents IC025 and PRR025, the lower ends of the 95% respective confidence intervals.

CI confidence interval; IC information component; N number of reports; PRR proportional reporting ratio.